|
104
|
348
|
3kf7A |
Crystal structure of human p38alpha complexed with a triazolopyrimidine compound |
|
66
|
267
|
3kmuA |
Crystal structure of the ilk/alpha-parvin core complex (apo) |
|
12
|
129
|
3kioC |
Mouse rnase h2 complex |
|
88
|
286
|
3kf4A |
Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a common vinyl purine template |
|
81
|
290
|
3kb7A |
Crystal structure of polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitor |
|
99
|
293
|
3krrA |
Crystal structure of jak2 complexed with a potent quinoxaline atp site inhibitor |
|
93
|
315
|
3kn6A |
Crystal structure of the c-terminal kinase domain of msk1 |
|
90
|
297
|
3kgaA |
Crystal structure of mapkap kinase 2 (mk2) complexed with a potent 3-aminopyrazole atp site inhibitor |
|
91
|
330
|
3kcfA |
Crystal structure of tgfbri complexed with a pyrazolone inhibitor |
|
83
|
273
|
3kulB |
Kinase domain of human ephrin type-a receptor 8 (epha8) |
|
83
|
271
|
3kmmA |
Structure of human lck kinase with a small molecule inhibitor |
|
90
|
284
|
3kk8A |
Camkii substrate complex a |
|
90
|
284
|
3kfaA |
Structural analysis of dfg-in and dfg-out dual src-abl inhibitors sharing a common vinyl purine template |
|
85
|
305
|
3kc3A |
Mk2 complexed to inhibitor n4-(7-(benzofuran-2-yl)-1h-indazol-5-yl)pyrimidine-2,4-diamine |
|
84
|
315
|
3krlA |
Cfms tyrosine kinase in complex with 5-cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide |
|
92
|
289
|
3kckA |
A novel chemotype of kinase inhibitors |
|
118
|
410
|
3k2lA |
Crystal structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (dyrk2) |
|
78
|
271
|
3jvsA |
Characterization of the chk1 allosteric inhibitor binding site |
|
107
|
348
|
3k3jA |
P38alpha bound to novel dfg-out compound pf-00416121 |
|
80
|
274
|
3jxwA |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
79
|
275
|
3jy0A |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
81
|
267
|
3k54A |
Structures of human bruton's tyrosine kinase in active and inactive conformations suggests a mechanism of activation for tec family kinases. |
|
89
|
289
|
3jy9A |
Janus kinase 2 inhibitors |
|
88
|
287
|
3k5vA |
Structure of abl kinase in complex with imatinib and gnf-2 |
|
83
|
269
|
3k5uA |
Identification, sar studies and x-ray cocrystal analysis of a novel furano-pyrimidine aurora kinase a inhibitor |
|
81
|
274
|
3jyaA |
Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective and orally bioavailable pim kinases inhibitors |
|
113
|
348
|
3k3iA |
P38alpha bound to novel dgf-out compound pf-00215955 |
|
88
|
302
|
3js2A |
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid |
|
102
|
296
|
3jr1A |
Crystal structure of putative fructosamine-3-kinase (yp_719053.1) from haemophilus somnus 129pt at 2.32 a resolution |
|
114
|
334
|
3juhA |
Crystal structure of a mutant of human protein kinase ck2alpha with altered cosubstrate specificity |
|
82
|
273
|
3jpvA |
Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a pyrrolo[2,3-a]carbazole ligand |
|
81
|
271
|
3jvrA |
Characterization of the chk1 allosteric inhibitor binding site |
|
112
|
349
|
3iphA |
Crystal structure of p38 in complex with a biphenylamide inhibitor |
|
109
|
350
|
3iw6A |
Human p38 map kinase in complex with a benzylpiperazin-pyrrol |
|
96
|
289
|
3io7A |
2-aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of jak2 |
|
110
|
357
|
3itzA |
Crystal structure of p38a mitogen-activated protein kinase in complex with a pyrazolopyridazine inhibitor |
|
80
|
285
|
3iopA |
Pdk-1 in complex with the inhibitor compound-8i |
|
97
|
289
|
3iokA |
2-aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of jak2 |
|
76
|
272
|
3is5A |
Crystal structure of cdpk kinase domain from toxoplasma gondii, tgme49_018720 |
|
86
|
339
|
3iw4A |
Crystal structure of pkc alpha in complex with nvp-aeb071 |
|
113
|
328
|
3iq7A |
Crystal structure of human haspin in complex with 5-iodotubercidin |
|
103
|
349
|
3iw7A |
Human p38 map kinase in complex with an imidazo-pyridine |
|
105
|
350
|
3iw5A |
Human p38 map kinase in complex with an indole derivative |
|
107
|
349
|
3iw8A |
Structure of inactive human p38 map kinase in complex with a thiazole-urea |
|
81
|
285
|
3ionA |
Pdk1 in complex with compound 8h |
|
82
|
298
|
3ig7A |
Novel cdk-5 inhibitors - crystal structure of inhibitor efp with cdk-2 |
|
150
|
465
|
3i7cA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with bumped kinase inhibitor na-pp2 |
|
152
|
469
|
3igoA |
Crystal structure of cryptosporidium parvum cdpk1, cgd3_920 |
|
80
|
325
|
3ikaA |
Crystal structure of egfr 696-1022 t790m mutant covalently binding to wz4002 |
|
82
|
298
|
3iggA |
Novel cdk-5 inhibitors - crystal structure of inhibitor efq with cdk-2 |
